SJ

Surinder Jit Kaur

Active Director Director DIN 08487523
DIN 08487523 First appointment Jun 2019 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2019
Shareholding value •••• Premium profile

About Surinder Jit Kaur

Data last updated:

Surinder Jit Kaur is a Director at Elfin Drugs Private Limited (since 2019). The company operates in Pharma. Elfin Drugs Private Limited reported revenue of ₹21.23 Cr (FY 2024).

DIN 08487523
Primary Designation Director
Industry Pharma
First Appointment 19 Jun 2019
Oldest Company Age 21 yrs
Largest company Elfin Drugs Private Limited · ₹21.23 Cr (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Elfin Drugs Private Limited U24231PB2005PTC028300
Director19 Jun 20192005₹21.23 Cr (FY 2024)Active

Board colleagues of Surinder Jit Kaur

NameDINCompanyDesignation
Dilpreet Singh01446357Elfin Drugs Private LimitedDirector

Directorship timeline

Open interactive timeline →
Elfin Drugs Private Limited
Premium access

Shareholding and investment profile for Surinder Jit Kaur

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Surinder Jit Kaur

Surinder Jit Kaur currently holds 1 directorship: Elfin Drugs Private Limited (Director, since 19 Jun 2019, revenue ₹21.23 Cr (FY 2024)).

Surinder Jit Kaur was first appointed on 19 Jun 2019 as Director at Elfin Drugs Private Limited.

The current boards of Surinder Jit Kaur's companies include Dilpreet Singh (Elfin Drugs Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available